Pathward Financial
board of directors continued | Pathward Financial
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
31 of 39
Related slides by other companies
Docebo
Investor Presentation
November 2023
experienced management and board | Docebo
NioCorp
Investor Presentation
January 2024
board of directors slide of we | NioCorp
Theravance Biopharma
Investor Conference
April 2023
strategic actions focused on continued value creation | Theravance Biopharma
Alkermes
Investor Day
March 2021
maintaining strong board of directors and corporate governance board composition and refreshment board skills and support strategy and long term value creation appointed new independent directors since new directors bring financial operational and oncology three longer serving directors have recently retired or announced their retirement from the board average director tenure years continued board refreshment efforts announced for proposal to shareholders to declassify the board to be included in proxy statement board oversight of value enhancement plan formed financial operating committee to oversee implementation of value enhancement plan compensation committee incorporated objective performance based elements related to value enhancement plan into company long term incentive plan for executives does not include two directors retiring at close of the company annual general meeting gender wormer | Alkermes
Other recent decks by Pathward Financial
See all presentations (23 decks)
Investor Presentation
October 2024
Investor Presentation
February 2024
Results
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights